We are a scientific consulting firm that is respected worldwide for its risk assessment experience, technical capabilities, industry leadership and pioneering spirit

We take an integrated, multi-disciplinary, and collaborative approach to evaluating nonclinical, clinical, and behavioral research and the associated public health impacts of nicotine products.

Our COVID-19 support team is advising on how organizations can respond, recover and reopen safely and effectively